Safety and Early Biologic Effects of Phase 1 PERIO-01 Trial of Pressure-Enabled Drug Delivery (PEDD) of TLR9 Agonist SD-101 and Immune Checkpoint Inhibition (ICI) in Uveal Melanoma Metastatic to the Liver (MUM).
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
Myeloid-derived suppressor cells
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined